Hans Hilpert

1.7k total citations
36 papers, 1.1k citations indexed

About

Hans Hilpert is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Hans Hilpert has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Organic Chemistry and 4 papers in Infectious Diseases. Recurrent topics in Hans Hilpert's work include Synthesis and Catalytic Reactions (7 papers), Synthesis and Biological Evaluation (6 papers) and Chemical Synthesis and Analysis (6 papers). Hans Hilpert is often cited by papers focused on Synthesis and Catalytic Reactions (7 papers), Synthesis and Biological Evaluation (6 papers) and Chemical Synthesis and Analysis (6 papers). Hans Hilpert collaborates with scholars based in Switzerland, Belgium and Hungary. Hans Hilpert's co-authors include Aǹdré S. Dreiding, Beat Wirz, Lienhard Hoesch, Jörg Benz, Bernd Kuhn, Uwe Grether, Hans Peter Märki, Peter Mohr, Markus Meyer and Alfred Binggeli and has published in prestigious journals such as Journal of Neuroscience, Cell Metabolism and Journal of Medicinal Chemistry.

In The Last Decade

Hans Hilpert

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Hilpert Switzerland 18 426 356 179 157 112 36 1.1k
Gilbert M. Rishton United States 15 754 1.8× 323 0.9× 90 0.5× 200 1.3× 450 4.0× 17 1.5k
Gino Salituro United States 20 803 1.9× 392 1.1× 147 0.8× 337 2.1× 36 0.3× 46 1.6k
Wolfgang Albrecht Germany 19 522 1.2× 396 1.1× 56 0.3× 187 1.2× 84 0.8× 69 1.2k
K. Yamaguchi Japan 23 1000 2.3× 314 0.9× 623 3.5× 167 1.1× 60 0.5× 89 1.7k
Shin‐Hun Juang Taiwan 25 814 1.9× 360 1.0× 301 1.7× 155 1.0× 81 0.7× 69 2.0k
Mohammed Jaffar United Kingdom 19 672 1.6× 340 1.0× 59 0.3× 54 0.3× 34 0.3× 39 1.3k
Shuangyan Zhou China 19 550 1.3× 176 0.5× 107 0.6× 179 1.1× 202 1.8× 44 1.1k
Vassilios Myrianthopoulos Greece 20 839 2.0× 438 1.2× 148 0.8× 92 0.6× 97 0.9× 49 1.5k
Joong Myung Cho South Korea 19 930 2.2× 180 0.5× 42 0.2× 129 0.8× 95 0.8× 36 1.3k
Sylva L. U. Schwager South Africa 24 1.6k 3.8× 193 0.5× 192 1.1× 110 0.7× 465 4.2× 45 2.3k

Countries citing papers authored by Hans Hilpert

Since Specialization
Citations

This map shows the geographic impact of Hans Hilpert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Hilpert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Hilpert more than expected).

Fields of papers citing papers by Hans Hilpert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Hilpert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Hilpert. The network helps show where Hans Hilpert may publish in the future.

Co-authorship network of co-authors of Hans Hilpert

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Hilpert. A scholar is included among the top collaborators of Hans Hilpert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Hilpert. Hans Hilpert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobsen, Helmut, Laurence Ozmen, Antonello Caruso, et al.. (2014). Combined Treatment with a BACE Inhibitor and Anti-Aβ Antibody Gantenerumab Enhances Amyloid Reduction in APPLondonMice. Journal of Neuroscience. 34(35). 11621–11630. 68 indexed citations
2.
Woltering, Thomas J., Wolfgang Wostl, Hans Hilpert, et al.. (2013). BACE1 inhibitors: A head group scan on a series of amides. Bioorganic & Medicinal Chemistry Letters. 23(14). 4239–4243. 43 indexed citations
3.
Esterházy, Daria, Haiyan Wang, Markus Rechsteiner, et al.. (2011). Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass. Cell Metabolism. 14(3). 365–377. 102 indexed citations
4.
Bot, Ilze, Martine Bot, Sandra H. van Heiningen, et al.. (2010). Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE−/− mice. Cardiovascular Research. 89(1). 244–252. 56 indexed citations
5.
Anselm, Lilli, David W. Banner, Jörg Benz, et al.. (2010). Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a clinical candidate. Bioorganic & Medicinal Chemistry Letters. 20(17). 5313–5319. 31 indexed citations
6.
Grether, Uwe, Agnès Bénardeau, Jörg Benz, et al.. (2009). Design and Biological Evaluation of Novel, Balanced Dual PPARα/γ Agonists. ChemMedChem. 4(6). 951–956. 25 indexed citations
7.
Bénardeau, Agnès, Jörg Benz, Alfred Binggeli, et al.. (2009). Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes. Bioorganic & Medicinal Chemistry Letters. 19(9). 2468–2473. 85 indexed citations
8.
Hilpert, Hans, et al.. (2006). Efficient Synthesis of Novel NK1 Receptor Antagonists:  Selective 1,4-Addition of Grignard Reagents to 6-Chloronicotinic Acid Derivatives. The Journal of Organic Chemistry. 71(5). 2000–2008. 27 indexed citations
9.
Kuhn, Bernd, Hans Hilpert, Jörg Benz, et al.. (2006). Structure-based design of indole propionic acids as novel PPARα/γ co-agonists. Bioorganic & Medicinal Chemistry Letters. 16(15). 4016–4020. 64 indexed citations
10.
Hilpert, Hans & Beat Wirz. (2001). Novel versatile approach to an enantiopure 19-nor, des-C,D vitamin D3 derivative. Tetrahedron. 57(4). 681–694. 54 indexed citations
12.
Coe, Diane M., Hans Hilpert, Stewart A. Noble, et al.. (1991). Synthesis of some mimics of nucleoside triphosphates. Journal of the Chemical Society Chemical Communications. 312–312. 27 indexed citations
13.
Hilpert, Hans & Aǹdré S. Dreiding. (1988). Triaziridine. 9. Mitteilung. Ringöffnungen von Triaziridinen. Helvetica Chimica Acta. 71(1). 277–291. 6 indexed citations
14.
Hilpert, Hans. (1987). Synthese von 3‐(2‐Carboxy‐4‐Pyridyl)‐ und 3‐(6‐Carboxy‐3‐pyridyl)‐DL‐alanin. Helvetica Chimica Acta. 70(5). 1307–1311. 3 indexed citations
15.
Hilpert, Hans, Lienhard Hoesch, & Aǹdré S. Dreiding. (1986). Azimines. VIII. Contribution to the Preparation and Thermolysis of Alkyl (2Z)-2,3-Diisopropyl-azimine-1-carboxylates. Croatica Chemica Acta. 58(4). 559–567.
16.
Hilpert, Hans, Lienhard Hoesch, & Aǹdré S. Dreiding. (1986). Triaziridine. 6. Mitteilung. Substituententransformationen an Triaziridinen. Helvetica Chimica Acta. 69(8). 2087–2097. 11 indexed citations
17.
Trifonov, Latchezar S., Hans Hilpert, Philipp Floersheim, et al.. (1986). Bisvertinols: a new group of dimeric vertinoids from. Tetrahedron. 42(12). 3157–3179. 60 indexed citations
19.
Hilpert, Hans & Aǹdré S. Dreiding. (1984). Über die Totalsynthese vo Betalainen. Helvetica Chimica Acta. 67(6). 1547–1561. 13 indexed citations
20.
Fischer, Ed. H. & Hans Hilpert. (1953). Purification of potato phosphorylase. Cellular and Molecular Life Sciences. 9(5). 176–177. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026